Ibrutinib resistance in chronic lymphocytic leukemia Journal Article


Authors: Furman, R. R.; Cheng, S.; Lu, P.; Setty, M.; Perez, A. R.; Guo, A.; Racchumi, J.; Xu, G.; Wu, H.; Ma, J.; Steggerda, S. M.; Coleman, M.; Leslie, C.; Wang, Y. L.
Article Title: Ibrutinib resistance in chronic lymphocytic leukemia
Keywords: adult; middle aged; treatment failure; mutation; disease course; case report; letter; polymerase chain reaction; allele; computer assisted tomography; amino acid substitution; serine; relapse; recurrence; drug resistance, neoplasm; enzyme activity; pyrimidines; phosphorylation; drug dose escalation; enzyme phosphorylation; blood sampling; pyrazoles; nucleotide sequence; drug response; protein-tyrosine kinases; point mutation; chronic lymphatic leukemia; lymphadenopathy; drug protein binding; leukemia, lymphocytic, chronic, b-cell; genomic dna; lymphocyte count; cysteine; electrophoresis; complementary dna; thymidine; rna sequence; enzyme active site; sequence analysis, dna; adenine; receptors, antigen, b-cell; covalent bond; drug concentration; thiol derivative; bruton tyrosine kinase; ibrutinib; humans; human; female; priority journal; maximal inhibitory concentration
Journal Title: New England Journal of Medicine
Volume: 370
Issue: 24
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2014-06-12
Start Page: 2352
End Page: 2354
Language: English
DOI: 10.1056/NEJMc1402716
PROVIDER: scopus
PUBMED: 24869597
PMCID: PMC4512173
DOI/URL:
Notes: New Engl. J. Med. -- Cited By (since 1996):1 -- Export Date: 8 July 2014 -- CODEN: NEJMA -- Molecular Sequence Numbers: GENBANK: NM_000061; -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christina Leslie
    188 Leslie
  2. Manu Setty
    35 Setty
  3. Alexandar Reinaldo Perez
    14 Perez